Literature DB >> 18175916

Effect of bovine lactoferrin on extracellular matrix calcification by human osteoblast-like cells.

Yoshiharu Takayama1, Koko Mizumachi.   

Abstract

Osteoblast-mediated calcium deposition to the extracellular matrix (ECM) is a critical step in bone tissue generation. Bovine lactoferrin enhanced the calcium deposition by MG63 human osteoblast-like cells cultured on collagen-coated plates. Lactoferrin also promoted the alkaline phosphatase activity and osteocalcin production during the calcification process, whereas it had little effect on the growth of the cells on the collagen-coated plates.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18175916     DOI: 10.1271/bbb.70465

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  4 in total

1.  Lactoferrin promote primary rat osteoblast proliferation and differentiation via up-regulation of insulin-like growth factor-1 expression.

Authors:  Jian-ming Hou; Man Wu; Qing-ming Lin; Fan Lin; Ying Xue; Xu-hua Lan; En-yu Chen; Mei-li Wang; Hai-yan Yang; Feng-xiong Wang
Journal:  Mol Biol Rep       Date:  2014-05-03       Impact factor: 2.316

2.  Effect of lactoferrin on osteogenic differentiation of human adipose stem cells.

Authors:  Xiaozhou Ying; Shaowen Cheng; Wei Wang; Zhongqin Lin; Qingyu Chen; Wei Zhang; Dongquan Kou; Yue Shen; Xiaojie Cheng; Lei Peng; Hua Zi Xu; Chuan Zhu Lu
Journal:  Int Orthop       Date:  2011-06-29       Impact factor: 3.075

3.  Human Mesenchymal Stem Cell Response to Lactoferrin-based Composite Coatings.

Authors:  Madalina Icriverzi; Anca Bonciu; Laurentiu Rusen; Livia Elena Sima; Simona Brajnicov; Anisoara Cimpean; Robert W Evans; Valentina Dinca; Anca Roseanu
Journal:  Materials (Basel)       Date:  2019-10-18       Impact factor: 3.623

4.  Comparison of the Anabolic Effects of Reported Osteogenic Compounds on Human Mesenchymal Progenitor-derived Osteoblasts.

Authors:  Robert Owen; Hossein Bahmaee; Frederik Claeyssens; Gwendolen C Reilly
Journal:  Bioengineering (Basel)       Date:  2020-01-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.